Go Pro
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel Free RVMDW Stock Alerts

Revolution Medicines (RVMDW) Competitors

Revolution Medicines logo
$9.39 +0.01 (+0.11%)
Closing price 07/1/2026 03:55 PM Eastern
Extended Trading
$9.65 +0.26 (+2.76%)
As of 07:33 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVMDW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Revolution Medicines stock or one of its competitors? MarketBeat compares Revolution Medicines with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Revolution Medicines include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Revolution Medicines compare to 60 Degrees Pharmaceuticals?

Revolution Medicines (NASDAQ:RVMDW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

In the previous week, Revolution Medicines and Revolution Medicines both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Revolution Medicines' score of 1.87 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Revolution Medicines Very Positive
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Revolution Medicines on 2 of the 2 factors compared between the two stocks.

How does Revolution Medicines compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Revolution Medicines N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than Revolution Medicines. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.52 indicating that Revolution Medicines is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Positive
Revolution Medicines Very Positive

Summary

Alpha Tau Medical and Revolution Medicines tied by winning 1 of the 2 factors compared between the two stocks.

How does Revolution Medicines compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Revolution Medicines N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 beat Revolution Medicines' score of 1.87 indicating that Apollomics is being referred to more favorably in the media.

Company Overall Sentiment
Apollomics Very Positive
Revolution Medicines Very Positive

Summary

Apollomics beats Revolution Medicines on 2 of the 2 factors compared between the two stocks.

How does Revolution Medicines compare to BioVie?

Revolution Medicines (NASDAQ:RVMDW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

In the previous week, BioVie had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.87 beat BioVie's score of 0.94 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Overall Sentiment
Revolution Medicines Very Positive
BioVie Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
BioVie N/A N/A N/A

Summary

Revolution Medicines and BioVie tied by winning 1 of the 2 factors compared between the two stocks.

How does Revolution Medicines compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

In the previous week, Cardio Diagnostics had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 1.87 beat Cardio Diagnostics' score of 1.43 indicating that Revolution Medicines is being referred to more favorably in the news media.

Company Overall Sentiment
Cardio Diagnostics Positive
Revolution Medicines Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Revolution Medicines N/A N/A N/A

Summary

Cardio Diagnostics beats Revolution Medicines on 2 of the 3 factors compared between the two stocks.

Get Revolution Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMDW vs. The Competition

Export
MetricRevolution MedicinesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$506.79M$6.79B$12.60B
Dividend YieldN/A3.87%2.66%6.14%
P/E RatioN/A3.1727.4325.27
Price / SalesN/A6,614.76537.9499.25
Price / CashN/A13.1347.9959.26
Price / BookN/A89.9411.026.62
Net IncomeN/A-$96.07M$3.57B$336.83M
7 Day Performance12.19%1.11%2.90%3.25%
1 Month Performance59.69%2.82%3.71%0.92%
1 Year Performance4,438.42%79.18%34.39%27.62%

Revolution Medicines Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMDW
Revolution Medicines
N/A$9.39
+0.1%		N/A+3,902.6%$0.00N/AN/A378
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-51.6%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.09
+4.8%		N/A+1,203.6%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
+9.5%		N/A-52.8%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.44
-2.2%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RVMDW) was last updated on 7/2/2026 by MarketBeat.com Staff.
From Our Partners
This Is How Financial Freedom Dies—And Most People Never See It Coming
While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...
Priority Gold | Sponsoredtc pixel
Urgent exposé on the "Mar-a-Lago Trade"
Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Gold Is About to Do Something It Hasn’t in 90 Years
The U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...
US Gold Bureau | Sponsoredtc pixel
The pre-flight check for options traders
Pilots never skip their pre-flight checklist - and neither should options traders. The Smart Trade Options Che...
Profits Run | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
They proved it worked in '76. Then buried it.
In 1976, Chevron, Unocal, and Texaco each confirmed the same energy technology worked - no fuel costs, no carb...
Behind the Markets | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel